Ziprax 100mg Tablet DT contains Cefixime, a third-generation cephalosporin antibiotic effective against a broad spectrum of Gram-positive and Gram-negative bacteria. This formulation is designed as a dispersible tablet, facilitating ease of administration, particularly in patients with swallowing difficulties. Cefixime acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death, thereby exerting a bactericidal effect. Ziprax is indicated for the treatment of various infections including uncomplicated urinary tract infections, acute otitis media, pharyngitis, tonsillitis, bronchitis, and gonorrhea caused by susceptible strains. The dispersible nature of the tablet allows rapid disintegration in water, enhancing patient compliance and convenience. Dosage and duration should be determined based on the severity and type of infection, as well as patient-specific factors such as age and renal function. Common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal pain, while hypersensitivity reactions are rare but possible. Caution is advised in patients with a history of cephalosporin or penicillin allergy. Ziprax 100mg Tablet DT should be used under medical supervision to ensure appropriate use and to minimize the development of antibiotic resistance.